Methoxetamine: Difference between revisions

>Josikins
No edit summary
>Josikins
No edit summary
Line 23: Line 23:
This substance was originally developed as a research chemical through the use of intelligent drug design.
This substance was originally developed as a research chemical through the use of intelligent drug design.
<ref>Interview with a ketamine chemist | http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php</ref>. It is a chemical derivative of [[Ketamine]] that also contains structural features of [[phencyclidine|phencyclidine (PCP)]] and [[3-MeO-PCP]].  
<ref>Interview with a ketamine chemist | http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704.php</ref>. It is a chemical derivative of [[Ketamine]] that also contains structural features of [[phencyclidine|phencyclidine (PCP)]] and [[3-MeO-PCP]].  
<ref>MXE Binding profile | http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/methoxetamine2012?view=Binary</ref>. MXE has almost no history of human usage prior and was first identified by the European Monitoring Centre for Drugs and Drug Addiction, which monitors the Internet for new psychoactive substances within the European Union, in November 2010. By July 2011, they had identified 58 websites selling the compound, at a cost of 145–195&nbsp;euros for 10&nbsp;grams.
<ref>MXE Binding profile | http://www.homeoffice.gov.uk/publications/agencies-public-bodies/acmd1/methoxetamine2012?view=Binary</ref>
 
MXE has almost no history of human usage prior and was first identified by the European Monitoring Centre for Drugs and Drug Addiction, which monitors the Internet for new psychoactive substances within the European Union, in November 2010. By July 2011, they had identified 58 websites selling the compound, at a cost of 145–195&nbsp;euros for 10&nbsp;grams.
<ref>Online sales of new psychoactive substances/‘legalhighs’ | http://www.emcdda.europa.eu/attachements.cfm/att_143801_EN_SnapshotSummary.pdf</ref>
<ref>Online sales of new psychoactive substances/‘legalhighs’ | http://www.emcdda.europa.eu/attachements.cfm/att_143801_EN_SnapshotSummary.pdf</ref>